ML-336

N/A

Report date: 2023/09/27 11:46:26
NME

Base Information

Drug NameML-336
Drug Alias NameML-336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThe non-structural protein 2 (nsP2) of Venezuelan equine encephalitis virus inhibitors
TargetsThe non-structural protein 2 (nsP2) of Venezuelan equine encephalitis virus
Therapy Area/IndicationsEncephalomyelitis, Venezuelan Equine
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kansas
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Kansas
Inactive CompaniesN/A
Active IndicationsEncephalomyelitis, Venezuelan Equine
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A